We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$29.4B
AUM Growth
+$2.35B
Cap. Flow
+$852M
Cap. Flow %
2.9%
Top 10 Hldgs %
20.99%
Holding
3,554
New
245
Increased
1,701
Reduced
1,372
Closed
145
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNST
3351
DELISTED
Pinstripes Holdings, Inc.
PNST
$27K ﹤0.01%
35,598
REFR icon
3352
Research Frontiers
REFR
$16.8M
$26K ﹤0.01%
12,000
OPTU
3353
Optimum Communications Inc
OPTU
$227M
$25K ﹤0.01%
10,075
DHY
3354
Credit Suisse High Yield Credit Fund
DHY
$239M
$25K ﹤0.01%
10,999
TRIB
3355
Trinity Biotech
TRIB
$7.86M
$25K ﹤0.01%
743
BTAI icon
3356
BioXcel Therapeutics
BTAI
$32.7M
$23K ﹤0.01%
2,378
GEVO icon
3357
Gevo
GEVO
$391M
$23K ﹤0.01%
14,008
HRTX icon
3358
Heron Therapeutics
HRTX
$64.7M
$23K ﹤0.01%
11,667
-3,200
-22% -$7.64K
PACB icon
3359
Pacific Biosciences
PACB
$345M
$22K ﹤0.01%
13,130
SGMO
3360
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$22K ﹤0.01%
25,790
+300
+1% +$220
GSAT icon
3361
Globalstar
GSAT
$10.8B
$21K ﹤0.01%
1,147
+294
+34% +$5.44K
BCTX
3362
Briacell Therapeutics
BCTX
$29.7M
$20K ﹤0.01%
+109
New +$12.2K
LAZR
3363
DELISTED
Luminar Technologies
LAZR
$20K ﹤0.01%
1,459
+384
+36% +$6.97K
PRPL icon
3364
Purple Innovation
PRPL
$28.4M
$20K ﹤0.01%
797
GOEV
3365
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$20K ﹤0.01%
1,042
-6
-0.6% -$201
GAN
3366
DELISTED
GAN Ltd
GAN
$19K ﹤0.01%
10,513
RJET
3367
Republic Airways Holdings
RJET
$962M
$19K ﹤0.01%
1,066
PSNY icon
3368
Polestar Automotive Holding UK
PSNY
$1.99B
$18K ﹤0.01%
358
-16
-4% -$517
OTLY
3369
Oatly Group
OTLY
$420M
$17K ﹤0.01%
1,006
-219
-18% -$4.11K
RVSN icon
3370
Rail Vision
RVSN
$10.2M
$17K ﹤0.01%
1,033
+666
+181% +$12.1K
VRCA icon
3371
Verrica Pharmaceuticals
VRCA
$87.4M
$17K ﹤0.01%
1,150
WW
3372
DELISTED
WW International
WW
$17K ﹤0.01%
19,589
+7,092
+57% +$6.88K
CHRS icon
3373
Coherus Oncology
CHRS
$181M
$16K ﹤0.01%
15,796
-3,789
-19% -$5.2K
GOSS icon
3374
Gossamer Bio
GOSS
$86.8M
$16K ﹤0.01%
16,000
ATAI icon
3375
AtaiBeckley Inc
ATAI
$2.68B
$15K ﹤0.01%
13,045
-629
-5% -$838

Similar funds

Cambridge Investment Research Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Cambridge Investment Research Advisors held 3,554 positions worth $29.4B, up 8.7% from $27.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q3 2024 filing shows 245 new, 1,701 increased, 1,372 reduced and 145 closed positions. Its largest new stake was Return Stacked US Stocks & Managed Futures ETF: 515,268 shares worth $12.6M. The largest sale was State Street Energy Select Sector SPDR ETF, an estimated $28.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q3 2024 buy was Return Stacked US Stocks & Managed Futures ETF: 515,268 shares worth $12.6M.
  • Cambridge Investment Research Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q3 2024, an estimated $69M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2024 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $28.7M.
  • Cambridge Investment Research Advisors fully exited Goldman Sachs MarketBeta US Equity ETF in Q3 2024, selling an estimated $3.98M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $29.4B portfolio in Q3 2024.
  • Cambridge Investment Research Advisors opened 245 new positions and closed 145 in Q3 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 8.7% quarter-over-quarter to $29.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2024, filed 28 Oct 2024.